Special Populations (Pediatric, Geriatric, Pregnancy) — MCQs

10 questions

Pseudotumor Cerebri in Infants is seen with?

Which of the following drugs can cause cartilage damage in children?

Which of the following drugs was classified as Category X (highest teratogenic risk) in the former FDA pregnancy risk classification system?

What is a potential consequence of administering indomethacin beyond 36 weeks of gestation?

All the following drugs are teratogenic except?

Which of the following drugs is known to have low first pass metabolism?

Which of the following antidepressants can be safely used in elderly depression?

A drug is more likely to cause toxicity in elderly patients due to all of the following reasons except which of the following?

Which of the following CNS tumor shows increased growth during pregnancy?

Q10

Plasma cholinesterase levels are affected by various conditions. Which of the following conditions does not typically reduce plasma cholinesterase levels?

Special Populations (Pediatric, Geriatric, Pregnancy) Indian Medical PG Practice Questions and MCQs

Question 1: Pseudotumor Cerebri in Infants is seen with?

A. Aminoglycosides
B. Tetracyclines (Correct Answer)
C. Macrolides
D. NSAIDs

Explanation: ***Tetracyclines***- **Tetracyclines**, particularly in infants, are a known cause of **pseudotumor cerebri**, also known as **idiopathic intracranial hypertension (IIH)**. - This condition involves increased **intracranial pressure (ICP)**, leading to symptoms like **headache**, **visual disturbances**, and **papilledema**. *Aminoglycosides*- **Aminoglycosides** are primarily associated with **ototoxicity** (hearing loss) and **nephrotoxicity** (kidney damage) [1]. - They are not typically linked to the development of **pseudotumor cerebri**. *NSAIDS*- **NSAIDs** (Nonsteroidal Anti-inflammatory Drugs) are more commonly associated with **gastrointestinal ulcers** and **renal impairment**. - While they can have neurological side effects in some cases, **pseudotumor cerebri** is not a characteristic or common adverse effect. *Macrolides*- **Macrolides** like erythromycin or azithromycin are generally well-tolerated and are primarily associated with **gastrointestinal upset** and **QT prolongation**. - There is no significant evidence linking **macrolide use** to the development of **pseudotumor cerebri**.

Question 2: Which of the following drugs can cause cartilage damage in children?

A. Cotrimoxazole and other sulfonamides
B. Penicillin and other beta-lactams
C. Metronidazole and other nitroimidazoles
D. Ciprofloxacin and other fluoroquinolones (Correct Answer)

Explanation: ***Ciprofloxacin and other fluoroquinolones*** - Fluoroquinolones, including ciprofloxacin, are known to cause **arthropathy** (joint disease) and **cartilage damage** in growing children and adolescents [1]. - This adverse effect has limited their use in pediatric populations, typically reserved for severe infections where other effective and safer alternatives are unavailable [1]. *Cotrimoxazole and other sulfonamides* - Sulfonamides are primarily associated with adverse effects like **hypersensitivity reactions** (e.g., Stevens-Johnson syndrome), **bone marrow suppression**, and **crystalluria**. - They are not typically linked to cartilage damage in children. *Penicillin and other beta-lactams* - Penicillins and other beta-lactam antibiotics are generally considered **safe in children** and are a common choice for pediatric infections. - Their primary adverse effects are hypersensitivity reactions, such as **rashes** or **anaphylaxis**, and gastrointestinal disturbances, not cartilage damage. *Metronidazole and other nitroimidazoles* - Metronidazole's main adverse effects include **gastrointestinal upset**, **metallic taste**, and **neurological symptoms** (e.g., peripheral neuropathy, seizures with high doses). - There is no known association between metronidazole and cartilage damage in children.

Question 3: Which of the following drugs was classified as Category X (highest teratogenic risk) in the former FDA pregnancy risk classification system?

A. Isotretinoin (Correct Answer)
B. Penicillin
C. Thiopental
D. Acetylsalicylic acid

Explanation: ***Isotretinoin*** - **Isotretinoin** is a powerful teratogen with **high risk of causing severe birth defects** including craniofacial, cardiac, thymic, and CNS malformations if taken during pregnancy. - Under the former FDA classification (discontinued 2015), it was Category X due to its significant teratogenic potential. - Requires strict contraception programs (iPLEDGE in US, pregnancy prevention programs globally) for all patients of childbearing potential. - **Absolute contraindication in pregnancy.** *Penicillin* - **Penicillin** was classified as Pregnancy Category B under the former system. - Generally considered **safe for use during pregnancy** when indicated for bacterial infections. - No evidence of teratogenic effects in human studies. - Widely used throughout pregnancy for appropriate indications. *Thiopental* - **Thiopental** was classified as Pregnancy Category C under the former system. - Used cautiously during pregnancy, typically only when **potential benefits outweigh risks**, primarily in situations requiring general anesthesia. - Short-term use for induction of anesthesia is generally considered acceptable when medically necessary. *Acetylsalicylic acid (Aspirin)* - **Aspirin** was Category C in first/second trimesters and Category D in third trimester under the former system. - **High doses and chronic use** carry risks including premature closure of **ductus arteriosus**, impaired platelet function, and increased bleeding risk. - Low-dose aspirin (75-150 mg) is now commonly used for prevention of preeclampsia in high-risk pregnancies. - Third trimester use of full doses should be avoided due to fetal and maternal bleeding complications.

Question 4: What is a potential consequence of administering indomethacin beyond 36 weeks of gestation?

A. Teratogenic
B. No effect
C. Premature closure of the patent ductus arteriosus (PDA) (Correct Answer)
D. Still birth
E. Oligohydramnios

Explanation: ***Premature closure of the patent ductus arteriosus (PDA)*** - **Indomethacin**, a non-steroidal anti-inflammatory drug (NSAID), inhibits **prostaglandin synthesis**, which is crucial for maintaining PDA patency in utero. - **Premature closure of the PDA** beyond 36 weeks of gestation can lead to **pulmonary hypertension** and **fetal heart failure**, as blood flow through the fetal circulation would be significantly altered. - This is the **most serious cardiovascular complication** of indomethacin use in late pregnancy. *Teratogenic* - While some medications can be teratogenic (cause birth defects), **indomethacin** is not generally considered to have a significant teratogenic risk when used in the third trimester. - The primary concern with NSAID use in late pregnancy is related to their effects on fetal circulation and renal function, not structural anomalies. *No effect* - This statement is incorrect because **indomethacin** has well-documented and significant effects on fetal circulation, particularly on the **ductus arteriosus**, especially in the third trimester. - Its mechanism of action profoundly impacts the maintenance of the fetal circulatory shunts. *Still birth* - While **indomethacin** use in late pregnancy can lead to serious fetal complications such as **pulmonary hypertension** and **renal dysfunction**, leading to **fetal compromise**, it does not directly or exclusively cause stillbirth. - The specific and most direct consequence on the cardiovascular system is the premature closure of the PDA. *Oligohydramnios* - While **oligohydramnios** (decreased amniotic fluid) can occur with prolonged NSAID use due to **decreased fetal urine output** from renal effects, this is not the primary concern beyond 36 weeks. - The more immediate and serious risk is **premature PDA closure** with its cardiovascular consequences.

Question 5: All the following drugs are teratogenic except?

A. Alcohol
B. Phenytoin
C. Warfarin
D. Metoclopramide (Correct Answer)

Explanation: ***Metoclopramide*** - **Metoclopramide** is an antiemetic and prokinetic agent generally considered **safe during pregnancy**. - It does **not** have established teratogenic effects and is often used to treat **nausea and vomiting** in pregnant women. *Alcohol* - **Alcohol** is a well-known teratogen, leading to **fetal alcohol syndrome** characterized by facial dysmorphia, growth restriction, and CNS abnormalities. - Even moderate consumption can have detrimental effects on fetal development, particularly brain development. *Phenytoin* - **Phenytoin** is an antiepileptic drug associated with **fetal hydantoin syndrome**, which includes craniofacial anomalies, mental deficits, and distal phalangeal hypoplasia. - It interferes with **folate metabolism** and can increase the risk of neural tube defects. *Warfarin* - **Warfarin** is an anticoagulant that can cause **fetal warfarin syndrome** when used during the first trimester, leading to chondrodysplasia punctata, nasal hypoplasia, and skeletal abnormalities. - Its mechanism involves interfering with **vitamin K-dependent coagulation factors**, affecting fetal bone and cartilage development.

Question 6: Which of the following drugs is known to have low first pass metabolism?

A. Lidocaine
B. Propranolol
C. Theophylline (Correct Answer)
D. Morphine

Explanation: ***Theophylline*** - **Theophylline** exhibits **low first-pass metabolism**, meaning a significant portion of the orally administered drug reaches systemic circulation unchanged. - This characteristic contributes to its relatively **high bioavailability** when given orally. *Lidocaine* - **Lidocaine** undergoes extensive **first-pass metabolism** in the liver, leading to very low oral bioavailability. - Due to this, it is typically administered **parenterally** (e.g., intravenously or topically) to achieve therapeutic concentrations. *Propranolol* - **Propranolol** is known for its significant **first-pass metabolism**, which results in a much lower bioavailability after oral administration compared to intravenous. - This extensive metabolism necessitates higher oral doses to achieve the same therapeutic effect as parenteral administration. *Morphine* - **Morphine** also undergoes substantial **first-pass metabolism** in the liver, where it is primarily glucuronidated. - This leads to a lower oral bioavailability compared to other routes of administration and contributes to a higher oral dose requirement.

Question 7: Which of the following antidepressants can be safely used in elderly depression?

A. phenelzine
B. mirtazapine (Correct Answer)
C. fluoxetine
D. trazodone

Explanation: ***Mirtazapine*** - Mirtazapine is often a good choice in elderly patients because it has a relatively **favorable side effect profile** in this population, causing less anticholinergic effects and orthostatic hypotension compared to many other antidepressants. - Its **sedating properties** can be beneficial for elderly patients who also suffer from insomnia, and its **appetite-stimulating effects** can help those with poor nutritional intake. *Phenelzine* - Phenelzine is a **monoamine oxidase inhibitor (MAOI)**, which carries a significant risk of **hypertensive crisis** due to interactions with tyramine-rich foods and many medications, making it generally unsafe for elderly use. - It also has a high incidence of other side effects, including **orthostatic hypotension** and **sedation**, which are particularly dangerous in older adults. *Fluoxetine* - Fluoxetine, an **SSRI**, has a very **long half-life** and can accumulate in elderly patients, increasing the risk of side effects like hyponatremia, gastrointestinal upset, and agitation. - While effective, its **activating properties** can exacerbate anxiety or insomnia in some elderly individuals, and there's a risk of **drug-drug interactions** due to its potent CYP2D6 inhibition. *Trazodone* - Trazodone is primarily used off-label at low doses for **insomnia** due to its prominent sedative effects, but it can cause significant **orthostatic hypotension** and cardiac arrhythmias in the elderly at antidepressant doses. - There is also a risk of **priapism** in men, and its strong sedative properties can lead to increased falls risk and daytime sleepiness, which are undesirable in the elderly.

Question 8: A drug is more likely to cause toxicity in elderly patients due to all of the following reasons except which of the following?

A. decreased renal excretion of drugs
B. decreased hepatic metabolism
C. decreased volume of distribution (Correct Answer)
D. increased receptor sensitivity

Explanation: ***decreased volume of distribution*** - A **decreased volume of distribution** would generally lead to a higher peak plasma concentration for a given dose, potentially increasing drug effect and thus toxicity, particularly for **hydrophilic drugs**. - However, for drugs that primarily distribute into **fat** or have a large volume of distribution, age-related changes in body composition (e.g., increased body fat, decreased total body water) can actually lead to an **increased volume of distribution** for some lipophilic drugs. *decreased renal excretion of drugs* - **Aging** is associated with a decline in **glomerular filtration rate (GFR)** and **renal tubular function**, leading to reduced drug clearance. - This results in a longer **half-life** and accumulation of renally excreted drugs, increasing the risk of **toxicity**. *decreased hepatic metabolism* - Liver size, blood flow, and the activity of some **cytochrome P450 enzymes** may decrease with age. - This leads to reduced **first-pass metabolism** and slower systemic clearance of many hepatically metabolized drugs, increasing their **bioavailability** and plasma concentrations. *increased receptor sensitivity* - Elderly patients often exhibit altered **pharmacodynamic responses**, including **increased sensitivity** to certain drugs. - This means a lower concentration of the drug at the receptor site can produce a greater therapeutic or toxic effect, making them more susceptible to **adverse drug reactions**.

Question 9: Which of the following CNS tumor shows increased growth during pregnancy?

A. Oligodendroglioma
B. Meningioma (Correct Answer)
C. Craniopharyngioma
D. Glioblastoma Multiforme

Explanation: ***Meningioma*** - **Meningiomas** often express receptors for **estrogen** and **progesterone**, leading to increased growth rates during the **estrogen-rich environment of pregnancy**. - This tumor's growth during pregnancy can exacerbate neurological symptoms or lead to the discovery of previously asymptomatic meningiomas. *Oligodendroglioma* - **Oligodendrogliomas** are a type of glioma that do not typically show an increased growth rate in response to hormonal changes during pregnancy. - Their growth is generally independent of **sex hormones**, and their progression is determined by other genetic and molecular factors. *Craniopharyngioma* - **Craniopharyngiomas** are benign epithelial tumors that arise from Rathke's pouch remnants and primarily affect children, though they can occur in adults. - Their growth is not significantly influenced by **hormonal changes** related to pregnancy. *Glioblastoma Multiforme* - **Glioblastoma multiforme (GBM)** is a highly aggressive and fast-growing primary brain tumor, but its growth is not directly stimulated by the hormonal changes of pregnancy. - While GBM can rapidly progress during pregnancy, this is due to its inherent aggressive nature rather than hormonal effects on tumor cells.

Question 10: Plasma cholinesterase levels are affected by various conditions. Which of the following conditions does not typically reduce plasma cholinesterase levels?

A. Pregnancy
B. Liver disease
C. Malnutrition
D. Chronic renal failure (Correct Answer)

Explanation: ***Chronic renal failure*** - While chronic renal failure can cause various metabolic derangements, it does not typically lead to a significant **reduction in plasma cholinesterase levels**. - Plasma cholinesterase is primarily synthesized in the liver, and its levels are more directly impacted by conditions affecting **liver function** or **protein synthesis** [1]. *Pregnancy* - **Plasma cholinesterase levels** are known to decrease during normal pregnancy, particularly in the third trimester. - This reduction is thought to be due to **hormonal changes** and possibly increased plasma volume. *Liver disease* - Since plasma cholinesterase is synthesized in the **liver**, severe **liver disease** (e.g., cirrhosis, acute hepatitis) significantly impairs its production [1]. - This leads to a marked **reduction in circulating enzyme levels**, which can affect drug metabolism [1]. *Malnutrition* - **Severe malnutrition**, especially protein-calorie malnutrition, can lead to decreased synthesis of many proteins, including plasma cholinesterase. - This is because the body lacks the necessary **amino acids** for enzyme production.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free